1Maekawa K, Sudoh T, Furusawa M, et al. Cloning and sequence analysis of cDNA encoding a precursor for porcine brain natrinretic peptide. Biochem Biophys Res Commun, 1988, 157(1): 410～416.
2Mukoyama M. Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest,1991,87(4):1 402～1 412.
3Tagashi K, Ando K, Hasegawa, et al. Concentrations of Bran Natriuretic Peptide Intreatcd Congestive Heart Failure.Clin Chem,1991.37(5):765.
4Motwani JG, McAlpine H, Kennedy N, et al. Plasma brain natriuretic peptide as an indicator for angiotensin coverting cazyme inhibition after myocardial infarction. Lancet, 1993, 341:1 109～1 113.
6Yandle TG. Biochemistry of natriuretic peptides. J Intern Med,1994,235(6):561～576.
7Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriurctic peptides family, atrial natriurctic peptides, brain natriurctic peptides and C-type natriurctic peptides. Endcrinology,1992,130(1):229～239.
8Kohno.M, Horio T, Yokokawa, et al. Brain Natriuretic Peptide as a Cardiac Hormune In Essential Hypertension. Am J Med,1992,92(1):29～34.
9Sudoh T, Minamino N, Kangawa, et al. Brain natriuretic peptide identificd in protein brain. Biochem Biophys res Commun, 1988,155(2):726～732.
10Hasbiguchi T. Higuchi K, Ohashi M, et al. Procine brain natriuretic peptide, another modulator of bovine adrenocortical steroidogenis. FEBS LETT,1988,236(2):455～61.
二级参考文献60
1[10]Charron F,Paradis P,Bronchain O,et a1.Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression.Mol Cell Bio1,1999,19(6):4355-4365.
3[12]Grantham JA,Borgeson DD,Burnett JC.BNP:pathophysiological and potential therapeutic roles in acute congestive heart failure.Am J Physiol,1997,92(2):R1077-1083.
4[13]Brunner-La Rocca HP,Kaye DM,Woods RL,et al.Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compard with healthy control subjects.JACC,2001,37(5):1221-1227.
5[14]Burrell LM,Lambert HJ,Baylis BH.Effect of atrial natriuretic peptide on thirst and arginine vasoperssin release in humans.Am J Physiol,1991,260(2):R475-479.
6[15]Cao L,Gardner DG.Natriuretic peptides inhibit DNA Synthesis in cardial fibroblasts.Hypertension,1995,25(2):227-234.
7[16]Haug C,Metzele A,Steffen J,et al.Increased brain natriuretic peptide and atrail peptide plasma concentration in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.Clin Invest,1994,72(6):430-434.
8[17]Kikuta K,Yasue H,Yoshimura M,et al.Increased plasma levels of B-type natriuretic peptide in patients with unstable angina.Am Heart J,1996,132(1):101-107.
9[18]Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.N Eng1 J Med,2002,347(3):161-167.
10[19]McDonagh TA,Morrison CE,Lawrence A,et al.Symptomatic and asymptomatic leftventricular systolic dysfunction in an urban population.Lancet,1997,350(9081):829-833.
6Sudoh T, Minamino N, Kangawa K, et el. C -type natriureticpeptide (CNP) : anew member of natriuretic peptide family idetified in porcine brain [ J ]. Biochem Biopys Res Commun, 1990,168:836 - 870.
7Rossi A, Burnett JC, Lerman A, et al. Natriuretic peptide levels in atrial fibrillation[J]. J Am Coll Cardiol, 2000,35 ( 5 ) : 1256 - 1261.
8Selvais PL, Donckier JE. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation[J]. Eur J Clin Invest,1998,28(8) :636 -642.
9Lerman A, Gibbons RJ . Circulating N - terminal atria natriuretic peptide as a marker for symptomless left ventricular dysfunction [ J ]. Lancet, 1993,341 (8853) : 1105 - 1109.
10Horie H, Tsutamoto T, Minai K, et al. Brain natriuretic peptide predicts chronic atrial fibrillation after ventrieular pacing in patients with sick sinus syndrome[J]. J P Cric,2000,64:965.
